Company Filing History:
Years Active: 2010
Title: Ulrich Von Pawel-Rammingen: Innovator in Immunology
Introduction
Ulrich Von Pawel-Rammingen is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of immunology, particularly through his research and innovations in protease activity.
Latest Patents
Ulrich holds a patent for a polypeptide that exhibits IgG cysteine protease activity. This protease, designated as IdeS, is crucial for its ability to degrade Immunoglobulin G. The polypeptide comprises SEQ ID NO: 1 and includes variants and fragments that maintain this activity. These polypeptides and their encoding polynucleotides can be utilized to generate an immune response in individuals. Furthermore, IdeS protease inhibitors have potential applications in treating infections.
Career Highlights
Ulrich is associated with Hansa Medical Research AB, where he continues to advance his research in immunology. His work has garnered attention for its potential therapeutic applications.
Collaborations
Ulrich collaborates with Lars Björck, contributing to the innovative research environment at Hansa Medical Research AB.
Conclusion
Ulrich Von Pawel-Rammingen's contributions to immunology through his patent and ongoing research highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in immune response therapies.